Company News, Financial News

Amyris Files Chapter 11 and Plans To Sell Consumer Brands

Future focus will be on competencies in sustainable ingredients R&D.

Author Image

By: Christine Esposito

Editor-in-Chief

Biotechnology company Amyris and certain domestic subsidiaries have commenced voluntary Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware. The company’s entities outside the US are not included in the proceedings. In its announcement on Aug. 9, the company said it is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the company for long-term success. The restructuring is intended ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters